FDA reclassifies NRx Pharmaceuticals ketamine application amendment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. PSKY
2. META
3. NVDA
4. LGND
5. SPY
6. MONC:IM
7. PTON
8. NYXH
9. MONRY
10. DGX

Go back to FDA reclassifies NRx Pharmaceuticals ketamine application amendment
(NASDAQ: NRXP) Delayed: 3.29 --0 (-0%)
Previous Close $3.29    52 Week High $ 
Open $3.29    52 Week Low $ 
Day High $3.29    P/E N/A 
Day Low $3.29    EPS $ 
Volume 3,694